Amukkara chooranam (Internal) and Vettiver thylam (External) for Psoriasis in Children

Clinical evaluation of Amukkara Chooranam(Internal) and Vettiver thylam (External) for Kalanajaga Padai (Psoriasis) in Children.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/06/008935

Enrollment

Registered

2017-06-29

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with age group of 5-12 years with symptoms of

Interventions

Intervention1: Amukkara Chooranam (Internal) Vettiver Thylam (External): Amukkara Chooranam (Int) 1gm bid for 45 days Vettiver Thylam (External Application ) for 45 days Control Intervention1: Not Ap

Eligibility

Inclusion criteria

Inclusion criteria: • Age: 5 â?? 12 years • Sex: Both male and female children. • Erythema • Thickness • Scaling • With or Without itching • Auspitz sign + • Candle crease sign + • Cracks followed by itching • Dryness of the skin

Exclusion criteria

Exclusion criteria: • Psoriatic arthritis • Psoriasis with evidence of .any other skin diseases • Fungal infestation • Systemic (cardiac) involvement

Design outcomes

Primary

Measure	Time frame
To assess the improvement by PASI Score.Timepoint: 45 days	—

Secondary

Measure	Time frame
clinical efficacy of the trail drug and its side effects if any Timepoint: 30 days	—

Countries

India

Contacts

Public ContactDr A M Amala Hazel

National Institute of Siddha

mmssiddha@rediffmail.com9940266442

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026